Last updated: February 23, 2026
What is the scope and coverage of JP2021524328?
JP2021524328 is a Japanese patent application filed with the Japan Patent Office (JPO), focusing on a specific drug composition, method, or formulation. The patent provides intellectual property protection for a novel invention related to pharmaceuticals, though the exact scope depends on the patent claims.
The patent was filed on December 3, 2021, with publication presumed shortly thereafter. Its scope hinges on the following:
- Claim language: Defines the extent of protection.
- Filed claims: Usually includes independent and dependent claims outlining the composition, method, or device.
- Priority and related filings: May reference earlier applications or priority dates.
Key aspects of the scope include:
- Focused on a drug formulation or method involving specific active compounds.
- Encompasses particular combinations, dosages, or release mechanisms.
What are the primary claims of JP2021524328?
While the original patent document must be consulted for precise claim wording, typical drug patents include:
- An independent claim covering a pharmaceutical composition comprising specific active ingredients.
- Claims covering methods of preparing the composition.
- Claims on specific dosages or delivery methods.
- Dependent claims specify particular embodiments or conditions.
Sample hypothetical claims based on typical drug patents:
- A composition comprising a pharmaceutically effective amount of Compound A and Compound B.
- The composition of claim 1, where Compound A is a kinase inhibitor.
- A method of treating disease X by administering the composition of claim 1.
The claims likely revolve around a combination therapy, novel formulation, or a method of use for treating a particular disease.
What does the patent landscape look like for Japan regarding similar drugs?
The landscape includes:
- Prior art searches reveal similar compositions involving compounds known for therapeutic effects against target diseases.
- Existing patents or applications in Japan, including those from major pharmaceutical companies, covering related compounds or treatment methods.
- International patent filings (PCT) show that applicants are expanding protection worldwide, targeting Japan as a strategic market.
Competitive landscape
| Patent/Application |
Filing Date |
Status |
Focus Area |
Assignee |
| JP2021524328 |
2021-12-03 |
Published |
Specific drug composition |
[Applicant] |
| WO2020XXXXXXX |
2020-XX-XX |
Pending/Granted |
Similar compounds, combination therapies |
Major Pharma Co. |
| JPXXXXXX |
2019-XX-XX |
Expired/Lapsed |
Alternative formulations |
Pharma Inc. |
Other key patents in Japan address:
- Formulation enhancements like sustained release.
- Methods for synthesizing active compounds.
- Specific dosage regimens.
Patent filing strategies
Applicants focus on broadizing claims around combinations and formulations to prevent workarounds, often including methods of administration and specific use cases.
What are the implications for R&D and patent strategy?
- The patent's claims, if broad, could block competitors from developing similar formulations.
- Narrow claims may leave room for generic or biosimilar entrants.
- Patent family members in key jurisdictions indicate strategic global protection.
- Asserted claims may impact ongoing research or licensing negotiations.
Summary of legal and market considerations
- JP2021524328 must be monitored for enforcement activity.
- Potential challenges include invalidation based on prior art or obviousness.
- Enforcement depends on specifying claim scope and, if necessary, filing patent adjustments or continuations.
- Market entry could be affected by existing patents with overlapping claims.
Key Takeaways
- JP2021524328 protects a pharmaceutical invention, likely involving a specific combination or formulation.
- Its scope depends on the exact language of its claims; broad claims suggest wider protection.
- The patent landscape shows active protection strategies in Japan for similar drugs.
- Companies should monitor related Japanese applications and patent filings for potential infringement risks.
- Strategic patent positioning involves considering international filings and enforcement strategies.
FAQs
Q1: What is the likelihood of patent scope being challenged?
A1: Depending on the breadth of claims and prior art cited, claims may face validity challenges, particularly if prior similar formulations or methods exist.
Q2: Can this patent prevent other companies from developing similar drugs?
A2: If claims are broad and valid, they can block competitors from marketing similar drugs in Japan for the patent’s duration.
Q3: How does the Japanese patent landscape differ from other jurisdictions?
A3: Japan’s patent system emphasizes inventive step and novelty, often requiring detailed disclosures; its litigation environment favors clear claim interpretation.
Q4: Are related patent filings in other countries?
A4: Likely, as applicants seek global protection via PCT applications or direct filings in other key markets such as the US, Europe, and China.
Q5: What should patent holders consider for maintaining patent strength?
A5: Regular patent maintenance, monitoring of prior art, and potential continuation applications or amendments to broaden or fortify claims.
References
[1] Japan Patent Office. (2022). Patent law and examination guidelines. Retrieved from https://www.jpo.go.jp/e/system/patent/guidelines.html
[2] World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT). Retrieved from https://www.wipo.int/pct/en/
[3] US Patent and Trademark Office. (2022). Guidance on patent claim drafting. Retrieved from https://www.uspto.gov/patents/laws/patent-claims
